The role of oncofetal CSA is published in a major article in ”Molecular Cancer Research” by the founders of VAR2Pharmaceuticals. The publication was choosen as the front cover of the monthly peer reviewed journal and describes that onco-fetal CSA plays a key role in metastasis formation and that treatment of animals with recombinant VAR2CSA hinders metastasis formation in vivo.